文章摘要

参考文献/References

［1］ Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction［J］. Circulation, 2001, 103(23): 2776-2779.

［2］ Woldbaek PR, Hoen IB, Christensen G, et al. Gene expression of colonystimulating factors and stem cell factor after myocardial infarction in the mouse［J］. Acta Physiol Scand, 2002, 175(3): 173-181.

［3］ Yamani MH, Cook DJ, Yang Yu, et al. Peritransplant Ischemic injury triggers mobilization of stem cells to allografts following heart transplantation［J］. JACC, 2005, 45(3 Supplement A): 1116-1153.

［4］ Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts［J］. Nature, 2004, 428(6983): 664-668.

［5］ Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium［J］. Nature, 2004, 428(6983): 668-673.

［6］ Deten A, Volz HC, Clamors S, et al. Hematopoietic stem cells do not repair the infarcted mouse heart［J］. Cardiovasc Res, 2005, 65(1): 52-63.

［7］ Couzin J , Vogel G. Cell therapy. Renovating the heart［J］. Science, 2004, 304(5668): 192-194.

［8］ Hescheler J, Fleischmann BK, Lentini S, et al. Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis［J］. Cardiovasc Res, 1997, 36(2): 149-162.

［9］ Soonpaa MH, Koh GY, Klug MG, et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium［J］. Science, 1994, 264(5155): 98-101.

［10］Scorsin M, Hagege AA, Marotte F, et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium?［J］. Circulation, 1997, 96(9 Suppl): Ⅱ188-Ⅱ193.

［11］Fraidenraich D, Stillwell E, Romero E, et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells［J］. Science, 2004, 306(5694): 247-252.

［12］Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and antideath strategies［J］. J Mol Cell Cardiol, 2001, 33(5): 907-921.

［13］Chiu RC, Zibaitis A, and Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation［J］. Ann Thorac Surg, 1995, 60(1): 12-18.

［14］Kessler PD ,Byrne BJ. Myoblast cell grafting into heart muscle: cellular biology and potential applications［J］. Annu Rev Physiol, 1999, 61: 219-242.

［15］Jain M, DerSimonian H, Brenner DA, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction［J］. Circulation, 2001, 103(14): 1920-1927.

［16］Dib N, McCarthy P, Campbell A, et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy［J］. Cell Transplant, 2005, 14(1): 11-19.

［17］Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow［J］. Nature, 2002, 418(6893): 41-49.

［18］Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium［J］. Nature, 2001, 410(6829): 701-705.

［19］Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival［J］. Proc Natl Acad Sci U S A, 2001, 98(18): 10344-10349.

［20］Yoshioka T, Ageyama N, Shibata H, et al. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model［J］. Stem Cells, 2005, 23(3): 355-364.

［21］Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells［J］. J Clin Invest, 2001, 107(11): 1395-1402.

［22］Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cellderived factor1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization［J］. Circulation, 2003, 107(9): 1322-1328.

［23］Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization［J］. Circ Res, 1999, 85(3): 221-228.

［24］Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bonemarrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function［J］. Nat Med, 2001, 7(4): 430-436.

［25］Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia［J］. Circulation, 2001, 103(5): 634-637.

［26］YlaHerttuala S and Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth［J］. Nat Med, 2003, 9(6): 694-701.

［27］Kawamoto A, Murayama T, Kusano K, et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor2 gene therapy in myocardial ischemia［J］. Circulation, 2004, 110(11): 1398-1405.

［28］Schuster MD, Kocher AA, Seki T, et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration［J］. Am J Physiol Heart Circ Physiol, 2004, 287(2): H525-H532.

［29］Galli D, Innocenzi A, Staszewsky L, et al. Mesoangioblasts, vesselassociated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endothelial cells［J］. Arterioscler Thromb Vasc Biol, 2005, 25(4): 692-697.

［30］Xu W, Zhang X, Qian H, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro［J］. Exp Biol Med (Maywood), 2004, 229(7): 623-631.

［31］Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function［J］. Circulation, 1999, 100(19 Suppl): II247-II256.

［32］Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects［J］. Ann Thorac Surg, 2002, 73(6): 1919-1925; discussion 1926.

［33］Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation［J］. J Thorac Cardiovasc Surg, 2002, 123(6): 1132-1140.

［34］Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart［J］. Circulation, 2002, 105(1): 93-98.

［35］Kuethe F, Richartz BM, Sayer HG, et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions［J］. Int J Cardiol, 2004, 97(1): 123-127.

［36］Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans［J］. Circulation, 2002, 106(15): 1913-1918.

［37］Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial［J］. Lancet, 2004, 364(9429): 141-148.

［38］Tse HF, Kwong YL, Chan JK, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation［J］. Lancet, 2003, 361(9351): 47-49.

［39］Stamm C, Westphal B, Kleine HD, et al. Autologous bonemarrow stemcell transplantation for myocardial regeneration［J］. Lancet, 2003, 361(9351): 45-46.

［40］Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final oneyear results of the TOPCAREAMI Trial［J］. J Am Coll Cardiol, 2004, 44(8): 1690-1699.

［41］Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy［J］. Circulation, 2004, 110(11 Suppl 1): II213-II218.

［42］FernandezAviles F, San Roman JA, GarciaFrade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction［J］. Circ Res, 2004, 95(7): 742-748.

［43］Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction［J］. Am J Cardiol, 2004, 94(1): 92-95.

［44］Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stemcells mobilised with granulocytecolony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial［J］. Lancet, 2004, 363(9411): 751-756.

［45］Limbourg FP ,Drexler H. Bone marrow stem cells for myocardial infarction: effector or mediator? ［J］. Circ Res, 2005, 96(1): 6-8.

［46］Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction［J］. Proc Natl Acad Sci U S A, 2003, 100(21): 12313-12318.

［47］Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca1positive cells differentiate into beating cardiomyocytes［J］. J Biol Chem, 2004, 279(12): 11384-11391.

［48］Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration［J］. Cell, 2003, 114(6): 763-776.

［49］Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages［J］. Nature, 2005, 433(7026): 647-653.

［50］Mummery CL. Cardiology: solace for the brokenhearted?［J］. Nature, 2005, 433(7026): 585-587.

［51］Li RK, Mickle DA, Weisel RD, et al. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury［J］. Ann Thorac Surg, 2001, 72(6): 1957-1963.

［52］Lu L, Zhang JQ, Ramires FJ, et al. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue［J］. Biochem Biophys Res Commun, 2004, 320(3): 907-913.

［53］Ren G, Michael LH, Entman ML, et al. Morphological characteristics of the microvasculature in healing myocardial infarcts［J］. J Histochem Cytochem, 2002, 50(1): 71-79.

［54］Perin EC, Assad JA, Silva GV, et al. Comparison between intracononary infusion and direct transendocardial injection of mesenchymal stem cells in a dog acute ischemia model［J］. J Am Coll Cardiol, 2005, 43(5 Suppl A): 63A.

［55］Vulliet PR, Greeley M, Halloran SM, et al. Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs［J］. Lancet, 2004, 363(9411): 783-784.

［56］Yoon YS, Park JS, Tkebuchava T, et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction［J］. Circulation, 2004, 109(25): 3154-3157.

［57］Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction［J］. J Am Coll Cardiol, 2003, 41(7): 1078-1083.

［58］Davidoff AM, Ng CY, Brown P, et al. Bone marrowderived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice［J］. Clin Cancer Res, 2001, 7(9): 2870-2879.

我们的网站为什么显示成这样？

干细胞移植治疗冠心病的应用进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics